Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 10, 2026 · Filed Nov 12, 2026
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
option exercise
Code M — exercise or conversion of a derivative security
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider buying
First insider buy since Oct 2024Traded Nov 9 · filed 3 days later
An Alnylam Pharmaceuticals director paid $300K out of pocket for Alnylam Pharmaceuticals shares. 1 other person at Alnylam Pharmaceuticals bought some too, in the same month. It was the first purchase in over a year.
Insider filing
Traded Nov 10 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider buying
Their first buy on recordTraded Nov 10 · filed 2 days later
An Alnylam Pharmaceuticals director paid $244K out of pocket for Alnylam Pharmaceuticals shares. 1 other person at Alnylam Pharmaceuticals bought some too, in the same month. It was the first purchase in over a year.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
